Overview
Hemasri Tokala is a Hematologist practicing medicine in Kalamazoo, Michigan.
Dr. Tokala is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Chronic Lymphocytic Leukemia (CLL), Inflammatory Breast Cancer, and Thrombocytopenia.
She is actively involved in clinical research, co-authoring 12 peer reviewed articles.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2520 Robert Jones Way, Kalamazoo, MI 49009
555 Linn St, Allegan, MI 49010
Frequently Asked Questions about Dr. Hemasri Tokala
How do I make an appointment with Dr. Hemasri Tokala?
You can book an appointment with Dr. Hemasri Tokala by calling their office at 269-552-0420. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Hemasri Tokala a top-rated expert for Paget Disease of the Breast?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Hemasri Tokala is classified as an Distinguished expert for Paget Disease of the Breast, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Hemasri Tokala specialize in?
While Dr. Hemasri Tokala is a Hematology, they have specific expertise in Paget Disease of the Breast, Chronic Lymphocytic Leukemia (CLL), and Inflammatory Breast Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Hemasri Tokala accept my insurance?
Dr. Hemasri Tokala accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 269-552-0420 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Paget Disease of the BreastDr. Tokala isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Tokala isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Adult Soft Tissue SarcomaDr. Tokala isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Breast CancerDr. Tokala isAdvanced. Learn about Breast Cancer.
- Chronic Lymphocytic Leukemia (CLL)
- Clear Cell SarcomaDr. Tokala isAdvanced. Learn about Clear Cell Sarcoma.
- Experienced
- Acute Hepatic Porphyria (AHP)Dr. Tokala isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- Acute Mountain SicknessDr. Tokala isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Adult Immune ThrombocytopeniaDr. Tokala isExperienced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Tokala isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Tokala isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.